Literature DB >> 21854362

Application of hyperthermia for cancer treatment: recent patents review.

Paula I P Soares1, Isabel M M Ferreira, Rui A G B N Igreja, Carlos M M Novo, Joao P M R Borges.   

Abstract

Cancer is one of the main causes of death in the world and its incidence increases every day. Current treatments are insufficient and present many breaches. Hyperthermia is an old concept and since early it was established as a cancer treatment option, mainly in superficial cancers. More recently the concept of intracellular hyperthermia emerged wherein magnetic particles are concentrated at the tumor site and remotely heated using an applied magnetic field to achieve hyperthermic temperatures (42-45°C). Many patents have been registered in this area since the year 2000. This review presents the most relevant information, organizing them according to the hyperthermic method used: 1) external Radio-Frequency devices; 2) hyperthermic perfusion; 3) frequency enhancers; 4) apply heating to the target site using a catheter; 5) injection of magnetic and ferroelectric particles; 6) injection of magnetic nanoparticles that may carry a pharmacological active drug. The use of magnetic nanoparticles is a very promising treatment approach since it may be used for diagnostic and treatment. An ideal magnetic nanoparticle would be able to detect and diagnose the tumor, carry a pharmacological active drug to be delivered in the tumor site, apply hyperthermia through an external magnetic field and allow treatment monitoring by magnetic resonance imaging.

Entities:  

Mesh:

Year:  2012        PMID: 21854362     DOI: 10.2174/157489212798358038

Source DB:  PubMed          Journal:  Recent Pat Anticancer Drug Discov        ISSN: 1574-8928            Impact factor:   4.169


  15 in total

Review 1.  Designing protein-based biomaterials for medical applications.

Authors:  Jennifer E Gagner; Wookhyun Kim; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2013-10-09       Impact factor: 8.947

2.  Spherical porous hydroxyapatite granules containing composites of magnetic and hydroxyapatite nanoparticles for the hyperthermia treatment of bone tumor.

Authors:  Masanobu Kamitakahara; Naohiro Ohtoshi; Masakazu Kawashita; Koji Ioku
Journal:  J Mater Sci Mater Med       Date:  2016-03-16       Impact factor: 3.896

3.  Antitumor effect and immune response induced by local hyperthermia in B16 murine melanoma: Effect of thermal dose.

Authors:  Dan Ye Li; Yang Ping Tang; Ling Yun Zhao; Chuan Ying Geng; Jin Tian Tang
Journal:  Oncol Lett       Date:  2012-07-16       Impact factor: 2.967

4.  Inhibition of mTOR promotes hyperthermia sensitivity in SMMC-7721 human hepatocellular carcinoma cell line.

Authors:  Qing-Liang Wang; B O Liu; Xiao-Jie Li; Kun-Peng Hu; Kun Zhao; Xiao-Ming Ye
Journal:  Exp Ther Med       Date:  2016-01-11       Impact factor: 2.447

5.  Gold-coated iron oxide nanoparticles trigger apoptosis in the process of thermo-radiotherapy of U87-MG human glioma cells.

Authors:  Ali Neshastehriz; Zohreh Khosravi; Habib Ghaznavi; Ali Shakeri-Zadeh
Journal:  Radiat Environ Biophys       Date:  2018-09-10       Impact factor: 1.925

6.  High temperature hyperthermia treatment for canines exhibiting superficial tumors: A report of three cases.

Authors:  Hidefumi Takagi; Kazuo Azuma; Tomohiro Osaki; Norihiko Itoh; Shinichi Nakazumi; Yasuho Taura; Yoshiharu Okamoto
Journal:  Oncol Lett       Date:  2014-09-03       Impact factor: 2.967

7.  Antitumor effects of high-temperature hyperthermia on a glioma rat model.

Authors:  Hidefumi Takagi; Kazuo Azuma; Takeshi Tsuka; Tomohiro Imagawa; Tomohiro Osaki; Yoshiharu Okamoto
Journal:  Oncol Lett       Date:  2014-02-04       Impact factor: 2.967

8.  Local hyperthermia for esophageal cancer in a rabbit tumor model: Magnetic stent hyperthermia versus magnetic fluid hyperthermia.

Authors:  Jiayi Liu; Ning Li; Li Li; Danye Li; Kai Liu; Lingyun Zhao; Jintian Tang; Liya Li
Journal:  Oncol Lett       Date:  2013-10-11       Impact factor: 2.967

9.  Cryo-thermal therapy elicits potent anti-tumor immunity by inducing extracellular Hsp70-dependent MDSC differentiation.

Authors:  Jun Zhu; Yan Zhang; Aili Zhang; Kun He; Ping Liu; Lisa X Xu
Journal:  Sci Rep       Date:  2016-06-03       Impact factor: 4.379

10.  A new mild hyperthermia device to treat vascular involvement in cancer surgery.

Authors:  Matthew J Ware; Lam P Nguyen; Justin J Law; Martyna Krzykawska-Serda; Kimberly M Taylor; Hop S Tran Cao; Andrew O Anderson; Merlyn Pulikkathara; Jared M Newton; Jason C Ho; Rosa Hwang; Kimal Rajapakshe; Cristian Coarfa; Shixia Huang; Dean Edwards; Steven A Curley; Stuart J Corr
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.